Presentation + Paper
19 May 2022 Influence of annealing temperature on the cytotoxicity upconversion nanoparticles on different cell lines
Author Affiliations +
Abstract
Carriers based on upconversion nanoparticles (UCNPs) and cyanine dye are suitable for theranostic application in oncology, although care must be taken for selection of the surface coating material, UCNP surface charge, size, and dosage of the material. Investigation of influence of annealing temperature of particles on the upconversion luminescence properties and cytotoxic effect are relevant. The present work demonstrates the assessment of cytotoxicity UCNPs unannealed and annealed at 550 oC on different normal and cancer murine cell lines in vitro. The cell viability is scored for cytotoxic effects of UCNPs at dark conditions. UCNPs provide a dose-dependent and time-dependent cytotoxic effect on all studied cell lines which was most pronounced for the Raw264.7 cell line. It is probably caused by the high phagocytic activity of macrophages. The statistically significant differences in cell viability after 24, 48 and 72 h of incubation of cells with particles were observed just for the macrophage cell line. It is also worth noting that annealed particles are less toxic than unannealed ones.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
R. A. Verkhovskii, R. A. Anisimov, M. V. Lomova, D. K. Tuchina, E. N. Lazareva, A. A. Doronkina, A. M. Mylnikov, N. A. Navolokin, V. I. Kochubey, and I. Yu. Yanina "Influence of annealing temperature on the cytotoxicity upconversion nanoparticles on different cell lines", Proc. SPIE 12147, Tissue Optics and Photonics II, 121470H (19 May 2022); https://doi.org/10.1117/12.2621543
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Particles

Photodynamic therapy

Annealing

Nanoparticles

Upconversion

Temperature metrology

Cancer

Back to Top